Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03002922 · ClinicalTrials.gov registry record · NA

Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)

A NA study of Sunscreening Agents, sponsored by Bayer.

Completed
Registry status
NA
Development phase
17
Enrollment target
1
Study location

NCT03002922: Completed NA study of Sunscreening Agents, sponsored by Bayer.

NCT03002922 is a NA study of Sunscreening Agents that has completed, run by Bayer. The registered enrollment target is 17 participants, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03002922, a NA study of Sunscreening Agents, has completed, sponsored by Bayer.

COMPLETED
Registry status
NA
Development phase
17 participants
Enrollment target
1
Study location

Study Summary

To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise

Primary Outcome

The expert grader will determine the percentage of coverage achieved by viewing the subject's face through the Skin Scanner

Conditions Studied

Interventions

  • DRUG BAY987517

Study Locations (1)

Florida

  • Hill Top Research - St. Petersburg

Trial Details

FieldValue
Enrollment Target 17 participants
Start Date 2017-01-18
Est. Completion 2017-01-28
Phase NA
Bayer

591 total trials

What the finished NCT03002922 record still lists

NCT03002922 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 80-participant average among 21 other Sunscreening Agents trials with a reported enrollment target (79% lower).

The record links to 1 condition, with Sunscreening Agents appearing as the primary indexed condition, and to 1 intervention - of which BAY987517 is the first listed.

NCT03002922 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT03002922 about?

NCT03002922 is a clinical study titled "Evaluation of Sunscreen During Exercise Under Conditions of Profuse Sweating (821/2016)". To visually evaluate the retention of coverage of the Test Product(s) (TP) on the face after exercise compared to the full coverage observed prior to exercise

What is the current status of trial NCT03002922?

This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2017-01-18. Estimated completion is 2017-01-28.

What conditions does trial NCT03002922 study?

This clinical trial studies the following conditions: Sunscreening Agents.

What interventions are being tested in trial NCT03002922?

The interventions under investigation include: BAY987517 (DRUG).

Who is sponsoring clinical trial NCT03002922?

This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03002922 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sunscreening Agents

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03002922's enrollment target sits among peer trials

17 8th of 21 higher than 14 of 21 other Sunscreening Agents trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Sunscreening Agents trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02090140 · 17 participants · NA

    Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects

  • NCT03317860 · 17 participants · NA

    Improving Measurement and Treatment of Post-stroke Neglect

  • NCT04356469 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children

  • NCT04414046 · 17 participants · Phase 2

    TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03002922, the US trial registry maintained by the National Library of Medicine. NCT03002922 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.